NEA Management Company, LLC
26 holdingsFiling period: 2026-03-31Current AUM: $1.90Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx, Inc. | 3.05M | $349.7M | $349.7M | 18.41% | -- | 2026-03-31 |
| 2 | CELC | Celcuity Inc. | 2.29M | $260.9M | $197.4M | 10.39% | -1,250,000 | 2026-03-31 |
| 3 | SGP | Spyglass Pharma, Inc. | 7.39M | $191.5M | $166.5M | 8.77% | -- | 2026-03-31 |
| 4 | TRVI | Trevi Therapeutics, Inc. | 13.22M | $157.7M | $241.3M | 12.70% | -- | 2026-03-31 |
| 5 | SVRA | Savara, Inc. | 24.47M | $133.6M | $133.6M | 7.03% | -- | 2026-03-31 |
| 6 | GLUE | Monte Rosa Therapeutics, Inc. | 7.69M | $126.5M | $127.1M | 6.69% | -- | 2026-03-31 |
| 7 | MBX | MBX Biosciences, Inc. | 3.61M | $107.9M | $238.3M | 12.55% | -- | 2026-03-31 |
| 8 | ZBIO | Zenas BioPharma, Inc. | 4.02M | $78.7M | $126.5M | 6.66% | +500.0K | 2026-03-31 |
| 9 | COUR | Coursera, Inc. | 12.87M | $74.9M | $68.3M | 3.60% | -- | 2026-03-31 |
| 10 | AUPH | Aurinia Pharmaceuticals, Inc. | 3.97M | $58.8M | $59.1M | 3.11% | -- | 2026-03-31 |
| 11 | ORIC | ORIC Pharmaceuticals, Inc. | 4.12M | $52.2M | $45.6M | 2.40% | -- | 2026-03-31 |
| 12 | — | CRISPR Therapeutics AG | 1.06M | $50.4M | $50.4M | 2.65% | -- | 2026-03-31 |
| 13 | PHAT | Phathom Pharmaceuticals, Inc. | 1.96M | $21.8M | $17.2M | 0.90% | -- | 2026-03-31 |
| 14 | CVRX | CVRx, Inc. | 2.03M | $19.2M | $10.5M | 0.55% | -- | 2026-03-31 |
| 15 | KRRO | Korro Bio, Inc. | 1.30M | $14.7M | $13.5M | 0.71% | +207.1K | 2026-03-31 |
| 16 | ASNS | X4 Pharmaceuticals, Inc. | 3.23M | $13.4M | $13.4M | 0.70% | -- | 2026-03-31 |
| 17 | CSBR | Champions Oncology, Inc. | 1.71M | $9.9M | $9.2M | 0.48% | -- | 2026-03-31 |
| 18 | BDTX | Black Diamond Therapeutics, Inc. | 4.45M | $9.5M | $7.5M | 0.40% | -- | 2026-03-31 |
| 19 | IVA | Inventiva SA | 1.46M | $8.0M | $6.5M | 0.34% | -- | 2026-03-31 |
| 20 | NKTX | Nkarta, Inc. | 3.57M | $7.5M | $7.5M | 0.39% | -- | 2026-03-31 |
| 21 | LONA | LeonaBio, Inc. | 464.4K | $4.8M | $3.3M | 0.17% | -- | 2026-03-31 |
| 22 | — | Senti Biosciences, Inc. | 3.78M | $3.1M | $3.1M | 0.16% | -- | 2026-03-31 |
| 23 | MRKR | Marker Therapeutics, Inc. | 1.63M | $2.1M | $1.8M | 0.10% | -- | 2026-03-31 |
| 24 | OKUR | OnKure Therapeutics, Inc. | 478.5K | $2.0M | $1.8M | 0.10% | -- | 2026-03-31 |
| 25 | GOSS | Gossamer Bio, Inc. | 1.00M | $328K | $169K | 0.01% | -17,093,034 | 2026-03-31 |
← Scroll →
Page 1 of 2